Physician profile
Christopher T Chen
NPI 1245235688
$8,617.27
in general payments reported to CMS, 2019-2025
30 companies · $521 in 2025
The $521 reported for 2025 was more than what 75% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,147 · 2020: $311 · 2021: $684 · 2022: $843 · 2023: $724 · 2024: $387 · 2025: $521.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,632.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,631.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novocure INC. | $5,326.94 | 2019-2024 | Optune |
| Janssen Biotech, INC. | $597.34 | 2019-2023 | Erleada |
| Myriad Genetic Laboratories, INC. | $571.51 | 2022-2025 | Prolaris |
| Dendreon Pharmaceuticals LLC | $368.54 | 2020-2025 | Provenge |
| Novartis Pharmaceuticals Corporation | $255.84 | 2020-2025 | |
| Regeneron Healthcare Solutions, INC. | $170.07 | 2022 | |
| Medtronic, INC. | $166.06 | 2022-2025 | Intellis Adaptivestim, Synchromedii |
| Gt Medical Technologies, INC | $158.87 | 2025 | Gammatile |
| Boston Scientific Corporation | $148.48 | 2019-2024 | Spaceoar Vue System - 10ml |
| Advanced Accelerator Applications | $128.55 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $83.38 | 2019-2022 | |
| Monteris Medical Corporation | $66.29 | 2023 | Neuroblate |
| Myovant Sciences INC. | $62.16 | 2021-2022 | |
| Blue Earth Diagnostics | $59.81 | 2022-2023 | |
| Sumitomo Pharma America, INC. | $50.64 | 2023 | Orgovyx |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Siemens Medical Solutions USA, INC. | $48.66 | 2022 | |
| Tactile Systems Technology INC | $48.60 | 2023-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Palette Life Sciences, INC. | $40.99 | 2022 | |
| Reflexion Medical, INC. | $39.42 | 2022 | |
| Teleflex LLC | $33.64 | 2025 | Barrigel |
| Astrazeneca Pharmaceuticals Lp | $32.10 | 2025 | Tagrisso |
| Napo Pharmaceuticals INC | $30.01 | 2025 | Gelclair Concentrated Oral Gel |
| Telix Pharmaceuticals | $27.11 | 2024 | Illuccix |
| Abbvie INC. | $22.29 | 2025 | |
| Beone Medicines USA, INC. | $21.69 | 2025 | Tevimbra |
| Treace Medical Concepts, INC. | $17.30 | 2022 | |
| Beigene USA, INC. | $16.43 | 2024 | Tevimbra |
| Pfizer INC. | $13.29 | 2021 | |
| Kite Pharma, INC. | $11.26 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.